TD Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-2,592
Closed -$448K 1455
2015
Q1
$448K Sell
2,592
-27,408
-91% -$4.02M ﹤0.01% 1132
2014
Q4
$3.45M Buy
+30,000
New +$3.63M 0.01% 753
2013
Q4
Sell
-12,000
Closed -$803K 1332
2013
Q3
$803K Buy
12,000
+700
+6% +$48.2K ﹤0.01% 903
2013
Q2
$747K Buy
+11,300
New +$646K ﹤0.01% 875

Other funds holding SLXP

TD Asset Management's SLXP Position: Q2 2015 in Review

TD Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,592 shares — an estimated $448K sold.

TD Asset Management first reported a position in SLXP in Q2 2013 and held it in 4 quarters. The position peaked at $3.45M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • TD Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • TD Asset Management sold 2,592 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $448K.
  • TD Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 4 quarters.
  • TD Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.45M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on TD Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.